Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-24-139356
Filing Date
2024-12-23
Accepted
2024-12-23 11:11:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 11710
  Complete submission text file 0000950170-24-139356.txt   13241
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Subject) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-48691 | Film No.: 241571082
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 JERICHO QUADRANGLE, SUITE 100 JERICHO NY 11753
Business Address
Deutsch Todd (Filed by) CIK: 0001709836 (see all company filings)

Type: SCHEDULE 13D/A